Oculis aces the Phase 2 clinical trial for OCS-01 treating DME
Oculis reported positive results from Phase 2 clinical studies of OCS-01 for treating DME
Author: zoltanfulop
Cyclodextrins without holes are reality
The smallest possible cyclodextrins were synthesized by Japanese scientists. They are the first new small cyclodextrins since 1994 when the synthesis of the five membered cyclodextrin was described.